Hepatitis C Virus Prevalence in 50 U.S. States and D.C. by Sex, Birth Cohort, and Race: 2013-2016

• Authors: Heather Bradley, Georgia State University; Eric W. Hall, Emory University; Elizabeth M. Rosenthal, State Univ New York; Patrick Sullivan, Emory University; A. Blythe Ryerson, Centers for Disease Control and Prevention; Eli Rosenberg, Emory University
• Journal Title: HEPATOLOGY COMMUNICATIONS
• Volume: Volume 4, Number 3
• Publisher: JOHN WILEY & SONS LTD | 2020-01-14, Pages 355-370
• Type of Work: Article | Final Publisher PDF
• Publisher DOI: http://doi.org/10.1002/hep4.1457
• Subjects: Health Sciences, Public Health
• Keywords: Science & Technology; Life Sciences & Biomedicine; Gastroenterology & Hepatology; UNITED-STATES; NATIONAL-HEALTH; INFECTION; HIV; HCV; PREVENTION; SERVICES; PEOPLE; JAILS; DRUG

Abstract

Hepatitis C virus (HCV) infection is a leading cause of liver-related morbidity and mortality, and more than 2 million adults in the United States are estimated to be currently infected. Reducing HCV burden will require an understanding of demographic disparities and targeted efforts to reduce prevalence in populations with disproportionate disease rates. We modeled state-level estimates of hepatitis C prevalence among U.S. adults by sex, birth cohort, and race during 2013-2016. National Health and Nutrition Examination Survey data were used in combination with state-level HCV-related and narcotic overdose-related mortality data from the National Vital Statistics System and estimates from external literature review on populations not sampled in the National Health and Nutrition Examination Survey. Nationally, estimated hepatitis C prevalence was 1.3% among males and 0.6% among females (prevalence ratio [PR] = 2.3). Among persons born during 1945 to 1969, prevalence was 1.6% compared with 0.5% among persons born after 1969 (PR = 3.2). Among persons born during 1945 to 1969, prevalence ranged from 0.7% in North Dakota to 3.6% in Oklahoma and 6.8% in the District of Columbia. Among persons born after 1969, prevalence was more than twice as high in Kentucky, New Mexico, Oklahoma, and West Virginia compared with the national average. Hepatitis C prevalence was 1.8% among non-Hispanic black persons and 0.8% among persons of other races (PR = 2.2), and the magnitude of this disparity varied widely across jurisdictions (PR range: 1.3-7.8). Overall, 23% of prevalent HCV infections occurred among non-Hispanic black persons, whereas 12% of the population was represented by this racial group. These estimates provide information on prevalent HCV infections that jurisdictions can use for understanding and monitoring local disease patterns and racial disparities in burden of disease.